Aytu BioScience (NasdaqCM: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, announced on Wednesday that their partner SUDA Pharmaceuticals has completed the submission of ZolpiMist™ (zolpidem tartrate oral spray) for regulatory approval to the Australian Therapeutic Goods Administration (TGA). Aytu BioScience (NasdaqCM: AYTU), a specialty pharmaceutical company […]
